Market Cap

Galapagos NV Market Capitalization:

€2.50 Billion

EUR as of Jan. 1, 2024

US$2.77 Billion

business Galapagos NV Company Profile

Galapagos NV Main Stock Listing

Euronext: GLPGA

Market Capitalization History of Galapagos NV

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Galapagos NV market cap

Date Market Cap YoY Change
Jan. 1, 2024 €2.50 B -8.90%
Jan. 1, 2023 €2.75 B -30.08%
Jan. 1, 2022 €3.93 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Galapagos NV Categories

Belgium languages Healthcare languages Biotechnology
Belgium Healthcare Belgium Biotechnology

Stocks & Indices

Galapagos NV has the following listings and related stock indices.


Stock: Euronext: GLPGA

Stock: FSX: GXE

Stock: NASDAQ: GLPG

Stock: MTA: GXE

Stock: XETR: GXE

Stock: OTC: GLPGF

Stock: FSX: GXEA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.